National Natural Science Foundation of China

Muon g-2 doubles down with latest measurement, explores uncharted territory in search of new physics

Retrieved on: 
Thursday, August 10, 2023

The Muon g-2 collaboration describes the result in a paper that they submitted today to Physical Review Letters.

Key Points: 
  • The Muon g-2 collaboration describes the result in a paper that they submitted today to Physical Review Letters.
  • In addition to the larger data set, this latest g-2 measurement is enhanced by updates to the Fermilab experiment itself.
  • In 2020, the Muon g-2 Theory Initiative announced the best Standard Model prediction for muon g-2 available at that time.
  • Until then, physicists have a new and improved measurement of muon g-2 that is a significant step toward its final physics goal.

UMD Researcher Shows How A Common Fungus Eliminates Toxic Mercury from Soil and Water

Retrieved on: 
Friday, November 18, 2022

COLLEGE PARK, Md., Nov. 18, 2022 /PRNewswire-PRWeb/ --  A University of Maryland researcher and colleagues found that the fungus Metarhizium robertsii removes mercury from the soil around plant roots, and from fresh and saltwater. The researchers also genetically engineered the fungus to amplify its mercury detoxifying effects.

Key Points: 
  • Mercury pollution of soil and water is a worldwide threat to public health.
  • COLLEGE PARK, Md., Nov. 18, 2022 /PRNewswire-PRWeb/ -- A University of Maryland researcher and colleagues found that the fungus Metarhizium robertsii removes mercury from the soil around plant roots, and from fresh and saltwater.
  • Mercury pollution of soil and water is a worldwide threat to public health.
  • Microbiological analyses revealed that the genes in question expressed enzymes that break down highly toxic organic forms of mercury into less toxic, inorganic mercury molecules.

20n Bio Appoints LIANG Shide PhD, as Vice President of Computational Biology

Retrieved on: 
Friday, May 6, 2022

MALVERN, Penn., May 6, 2022 /PRNewswire/ -- 20n Bio , an AI-powered drug discovery startup focusing on designing new proteins for therapeutics, announced the appointment of LIANG Shide, PhD, as Vice President of Computational Biology, effective May 9, 2022.

Key Points: 
  • MALVERN, Penn., May 6, 2022 /PRNewswire/ -- 20n Bio , an AI-powered drug discovery startup focusing on designing new proteins for therapeutics, announced the appointment of LIANG Shide, PhD, as Vice President of Computational Biology, effective May 9, 2022.
  • "We are thrilled to have Dr. LIANG join 20n Bio in this critical role and at this pivotal time in the company.
  • Dr. LIANG also pioneered a set of advanced computational methods for protein structure and function analysis, and protein immunogenicity prediction.
  • 20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics.

Researchers Discover New Model for "Global" DNA Repair

Retrieved on: 
Wednesday, March 30, 2022

NEW YORK, March 30, 2022 /PRNewswire/ -- Two studies provide a radically new picture of how bacterial cells continually repair damaged sections (lesions) in their DNA.

Key Points: 
  • Given that damaged DNA can result in detrimental DNA code changes (mutations) and death, cells evolved to have DNA repair machineries.
  • Widely accepted work, including studies that led to a 2015 Noble Prize , had argued that TCR played a relatively small role in repair because it relied on a putative TCR factor that made only a marginal contribution to DNA repair.
  • A parallel process, global genome repair (GGR), was assumed to scan and fix most of DNA independent of transcription.
  • Both processes were thought to set the stage for nucleotide excision repair (NER), in which a damaged stretch of DNA was snipped out and replaced by an accurate copy.

SMOORE: Chinese Industry Leaders Are Committed to Exploring Harm Reduction of Vaping

Retrieved on: 
Friday, February 11, 2022

In recent years, Chinese vaping industry leaders RELX and SMOORE are committed to cross-disciplinary fundamental research on atomization mechanism, so as to explore the long-term health effects of vaping.

Key Points: 
  • In recent years, Chinese vaping industry leaders RELX and SMOORE are committed to cross-disciplinary fundamental research on atomization mechanism, so as to explore the long-term health effects of vaping.
  • In October 2020, a research program on vaping harm reduction jointly conducted by SMOORE and Tongji University was approved by National Natural Science Foundation of China.
  • As China's national standards of e-cigarettes come into effective, Chinese industry players will continue to increase their R&D investment and examine the harm reduction of vaping via scientific substantiation.
  • The Company is the worlds largest vaping device manufacturer in terms of revenue, accounting for 18.9% of the total global market share.

EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies

Retrieved on: 
Monday, January 24, 2022

Under the agreement, both parties will jointly develop hematopoietic stem cell regenerative therapies, including the development of innovative genetically-modified hematopoietic stem cell therapies and the exploration of novel biomarkers to optimize quality control for stem cell production.

Key Points: 
  • Under the agreement, both parties will jointly develop hematopoietic stem cell regenerative therapies, including the development of innovative genetically-modified hematopoietic stem cell therapies and the exploration of novel biomarkers to optimize quality control for stem cell production.
  • Hematopoietic stem cells (HSCs) have the potential for long-term self-renewal and can differentiate into various types of mature blood cells.
  • "This collaboration with Haihe Laboratory of Cell Ecosystem will further our exploration in the field of hematopoietic stem cells.
  • In 2021, EdiGene initiated a Phase I multicenter clinical trial of ET-01, its gene-editing hematopoietic stem cell therapy for transfusion-dependent -thalassemia.

Neuroregenerative Gene Therapy Treats Temporal Lobe Epilepsy in Rat Model

Retrieved on: 
Tuesday, January 4, 2022

In recent years, Chen's team has developed a novel neuroregenerative gene therapy that offers a potential new approach to treat a variety of neurological disorders.

Key Points: 
  • In recent years, Chen's team has developed a novel neuroregenerative gene therapy that offers a potential new approach to treat a variety of neurological disorders.
  • Neuroregenerative gene therapy is a new technology that uses viral vectors to deliver neural transcription factors to glial cells in the brain and directly convert glial cells into functional neurons in situ.
  • "This is the first time we apply neuroregenerative gene therapy to treat epilepsy and achieved success in animal models.
  • This new discovery has important guidance for future clinical applications using neuroregenerative gene therapy to treat different neurological disorders", Professor Chen pointed out the potential clinical significance of this study.

Worldwide Stroke Rates Dip Slightly over Time, but Overall Numbers Still High

Retrieved on: 
Thursday, December 16, 2021

The study focused on ischemic stroke, which is caused by blood clots and makes up 85% of stroke cases.

Key Points: 
  • The study focused on ischemic stroke, which is caused by blood clots and makes up 85% of stroke cases.
  • And worldwide stroke is the leading cause of death and a major cause of disability for adults."
  • Egypt and China had the most pronounced increases in stroke rates, with an increase of 1.4% in Egypt and 1.1% in China.
  • Similar to the stroke occurrence rate, the rate of death from stroke decreased slightly over the three decades, or by 1.6%, but the overall numbers were high.

Opportunities in the Global Scientific & Technical Publishing Market to 2025: Online Content, Fastest-Growing Segment, Surpasses Books in Total Sales

Retrieved on: 
Thursday, August 19, 2021

DUBLIN, Aug. 19, 2021 /PRNewswire/ -- The "Global Scientific & Technical Publishing 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 19, 2021 /PRNewswire/ -- The "Global Scientific & Technical Publishing 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • Coronavirus lockdowns, travel restrictions and trade disruptions made for a challenging year, but these factors did not keep the scientific and technical publishing market from posting underlying growth.
  • The report found that total sales increased 0.4% to $10.5 billion in 2020.
  • The report provides detailed market information for scientific and technical publishing, segmented by delivery medium: journals, books, online content, abstracting and indexing, and other activities (audio, video and CD-ROM).